Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION - MediXall Group, Inc. | mdxl_ex32z2.htm |
| EX-31.2 - CERTIFICATION - MediXall Group, Inc. | mdxl_ex31z2.htm |
| EX-31.1 - CERTIFICATION - MediXall Group, Inc. | mdxl_ex31z1.htm |
| 10-Q - QUARTERLY REPORT - MediXall Group, Inc. | mdxl_10q.htm |
EXHIBIT 32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of MediXall Group, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Neil Swartz, Interim Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: June 16, 2020 | /s/ Neil Swartz |
| Neil Swartz |
| Interim Chief Executive Officer |
| (Principal Executive Officer) |